Monogram Biosciences Announces First Quarter 2008 Financial Results Conference Call
April 21 2008 - 2:30PM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., April 21 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc., (NASDAQ:MGRM) announced that it will
hold a conference call on Thursday, May 1, 2008 at 4:30 p.m.
(Eastern Time) to discuss first quarter 2008 financial results. The
call will be hosted by Mr. William D. Young, Chairman and CEO of
Monogram. To participate in the live teleconference, please call
(877) 545-1402, or (719) 325-4903 for international callers,
fifteen minutes before the conference begins. Live audio of the
call will be simultaneously broadcast over the Internet and will be
available to members of the news media, investors and the general
public. Following the live broadcast, a replay of the call will
also be available at (888) 203-1112 or (719) 457-0820 for
international callers, through 11:59 p.m. (Eastern Time) on
Thursday, May 15, 2008. The replay passcode is 4170582. Access to
live and archived audio of the conference call will be available by
following the appropriate links at http://www.monogrambio.com/ and
clicking on the Investor Relations link. The information provided
on the teleconference is only accurate at the time of the
conference call, and Monogram will take no responsibility for
providing updated information except as required by law. About
Monogram Biosciences, Inc. Monogram is advancing individualized
medicine by discovering, developing and marketing innovative
products to guide and improve treatment of serious infectious
diseases and cancer. The Company's products are designed to help
doctors optimize treatment regimens for their patients that lead to
better outcomes and reduced costs. The Company's technology is also
being used by numerous biopharmaceutical companies to develop new
and improved antiviral therapeutics and vaccines as well as
targeted cancer therapeutics. More information about the Company
and its technology can be found on its web site at
http://www.monogrambio.com/. contacts: Alfred G. Merriweather
Jeremiah Hall Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700 amerriweather@ jeremiah.hall@
monogrambio.com fkhealth.com DATASOURCE: Monogram Biosciences, Inc.
CONTACT: Alfred G. Merriweather, Chief Financial Officer of
Monogram Biosciences, Inc., +1-650-624-4576, ; or Jeremiah Hall of
Feinstein Kean Healthcare for Monogram Biosciences, Inc.,
+1-415-677-2700, Web site: http://www.monogrambio.com/
Copyright
Monogram Technologies (NASDAQ:MGRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Monogram Technologies (NASDAQ:MGRM)
Historical Stock Chart
From Jul 2023 to Jul 2024